Vivos Therapeutics, Inc. (VVOS) — 10-K/A Filings
All 10-K/A filings from Vivos Therapeutics, Inc.. Browse 1 Amended Annual Report reports with AI-powered summaries and risk analysis.
10-K/A Filings (1)
-
Vivos Therapeutics Files 10-K/A Amendment
— Jul 30, 2024 Risk: medium
Vivos Therapeutics, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ending December 31, 2023. The filing, submitted on July 30, 2024,
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX